Colchicine
Total Payments
$522,445
Transactions
15
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $195,690 | 5 | 0 |
| 2022 | $48,238 | 3 | 0 |
| 2021 | $161,102 | 4 | 0 |
| 2020 | $39,138 | 1 | 0 |
| 2019 | $78,276 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $522,445 | 15 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CLOAK | Hikma Pharmaceuticals USA | $522,445 | 0 |
Top Doctors Receiving Payments for Colchicine
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | New York, NY | $522,445 | 15 |
Ad
Manufacturing Companies
- Hikma Pharmaceuticals USA $522,445
Product Information
- Type Drug
- Total Payments $522,445
- Total Doctors 0
- Transactions 15
About Colchicine
Colchicine is a drug associated with $522,445 in payments to 0 healthcare providers, recorded across 15 transactions in the CMS Open Payments database. The primary manufacturer is Hikma Pharmaceuticals USA.
Payment data is available from 2019 to 2023. In 2023, $195,690 was paid across 5 transactions to 0 doctors.
The most common payment nature for Colchicine is "Unspecified" ($522,445, 100.0% of total).
Colchicine is associated with 1 research study, including "CLOAK" ($522,445).